Processa Pharmaceuticals, Inc. (PCSA) Net income 2016–2025
Processa Pharmaceuticals, Inc. (PCSA) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$13.6MFY2025 · since FY2016: -$1.9M → $13.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $13.6M | +214.5% |
| FY2024 | -$11.8M | -6.5% |
| FY2023 | -$11.1M | +59.4% |
| FY2022 | -$27.4M | -140.0% |
| FY2021 | -$11.4M | +20.7% |
| FY2020 | -$14.4M | -329.3% |
| FY2019 | -$3.4M | +10.8% |
| FY2018 | -$3.8M | -102.8% |
| FY2017 | -$1.9M | +3.2% |
| FY2016 | -$1.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice